StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) shareholders

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.66+0.01 (+2.05%)

Close on Nov 13, 2026Market cap $10.05MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
8.5%
1M of 15M shares
Institutional holders
27
7 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
L1 Capital Global Opportunities Master Fund, Ltd.2,028,8859.99%13G (passive)Aug 17, 2026
Lind Global Fund III LP
Joint filing with Lind Global Partners III LLC (5.65%), Easton Jeff (5.65%)
1,094,8905.65%13G (passive)Aug 17, 2026
Law Custodial Inc.––13G (passive) amendmentDec 22, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of DAREValueChange% of portfolio
Vanguard Capital Management LLC640,8774.19%$1.35M+178,5720.00%
Geode Capital Management, LLC140,0930.92%$295.64K−37,7460.00%
US Bancorp \de\120,9200.79%$255.14K+29,5500.00%
Vanguard Fiduciary Trust Co91,2690.60%$192.58K+25,3310.00%
BlackRock, Inc.64,2480.42%$135.56K+47,2770.00%
State Street Corp47,4150.31%$100.05K+23,9000.00%
Jane Street Group, LLC36,0920.24%$76.15KNew0.00%
Northern Trust Corp34,2090.22%$72.18K+18,7780.00%
Hrt Financial LP22,4300.15%$47.00KNew0.00%
Virtu Financial LLC15,8030.10%$33.00KNew0.00%
LPL Financial LLC14,8890.10%$31.42K+2500.00%
Raymond James Financial Inc14,8640.10%$31.36K−4700.00%
Price T Rowe Associates Inc /Md/13,3180.09%$29.00K+3,0960.00%
StoneX Group Inc.11,1530.07%$24.75KNew0.00%
Objectivity Squared, LLC10,9150.07%$23.03K–0.01%
Farther Finance Advisors, LLC9,4500.06%$19.94K+1250.00%
UBS Group AG6,8100.04%$14.37K−36,5530.00%
Vanguard Global Advisers, LLC2,9400.02%$6.20K–0.00%
Bay Harbor Wealth Management, LLC1,3580.01%$2.87KNew0.00%
IFS Advisors, LLC9500.01%$2.00K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026271M8.5%7 / 114 / 50M0M
Q1 2026251M6.7%7 / 63 / 81M0M
Q4 2025271M6.5%11 / 46 / 40M0M
Q3 2025211M6.6%4 / 82 / 60M0M
Q2 2025231M5.9%2 / 55 / 30M0M
Q1 2025241M5.4%0 / 83 / 10M0M
Q4 2024251M5.1%7 / 63 / 30M0M
Q3 2024221M4.3%18 / 20 / 01M0M
Q2 202440M0.0%4 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

11 funds held DARE in Q2 2026, 82% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of DAREValue% of fundAs of
Vanguard Total Stock Market Index Fund471,4863.08%$994.84K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund161,3851.06%$340.52K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund78,0500.51%$174.05K0.00%May 31, 2026
iShares Micro-Cap ETF45,2890.30%$95.56K0.01%Jun 30, 2026
Fidelity Series Total Market Index Fund32,4730.21%$72.41K0.00%May 31, 2026
Fidelity Total Market Index Fund15,3260.10%$34.18K0.00%May 31, 2026
Vanguard Balanced Index Fund8,0060.05%$16.89K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund7,5710.05%$16.88K0.00%May 31, 2026
1290 VT Micro Cap Portfolio2,9780.02%$6.28K0.00%Jun 30, 2026
Total Stock Market Index Trust6260.00%$1.32K0.00%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund-600-0.00%-$1.27K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Sabrina Martucci JohnsonChef Executive Officer, Director962,0626.29%Feb 20, 2026
MarDee Haring-LaytonChief Accounting Officer––Feb 2, 2026
Jessica D. GrossmanDirector26,0660.17%Jul 2, 2026
Susan L. KelleyDirector23,6960.15%Jul 2, 2026
Robin Joan SteeleDirector293,2261.92%Jul 2, 2026
William H. RastetterDirector100,0280.65%Jul 2, 2026
Gregory W. MatzDirector31,3470.21%Jul 2, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Robin Joan Steele
Director
Jun 30, 2026Award+26,540––47,055
William H. Rastetter
Director
Jun 30, 2026Award+38,862––39,721
Jessica D. Grossman
Director
Jun 30, 2026Award+26,066––26,066
Gregory W. Matz
Director
Jun 30, 2026Award+30,805––30,847
Susan L. Kelley
Director
Jun 30, 2026Award+23,696––23,696
Roger Hawley
Director
Apr 11, 2019Buy+454,545$1.10$500.00K944,956
Roger Hawley
Director
Jun 11, 2018Buy+140,000$1.45$203.00K140,000
Sabrina Martucci Johnson
Chief Executive Officer, Director, 10% owner
Jul 19, 2017Award+962,062––962,062
Robin Joan Steele
Director
Jul 19, 2017Award+246,171––246,171
Lisa Walters-Hoffert
Chief Financial Officer
Jul 19, 2017Award+443,512––443,512
Roger Hawley
Director
Jul 19, 2017Award+182,697––182,697
Roger Hawley
Director
Jul 19, 2017Award+307,714––490,411
Paul A. Friedman
Director
Apr 3, 2017Award+10,273$0.73$7.50K18,819
William H. Rastetter
Director
Jan 3, 2017Award+24,350$0.77$18.75K103,039
David Ross Parkinson
Director
Jan 3, 2017Award+16,234$0.77$12.50K28,488
David R. Walt
Director
Jan 3, 2017Award+14,935$0.77$11.50K193,700
Paul A. Friedman
Director
Jan 3, 2017Award+4,870$0.77$3.75K8,546
Stuart A. Arbuckle
Director
Jan 3, 2017Award+7,467$0.77$5.75K13,104
William McKee
Director
Jan 3, 2017Award+1,948$0.77$1.50K3,418
Christopherd T. Guiffre
Chief Executive Officer, Director
Dec 31, 2016Award+5,733$0.60$3.44K12,489
David Ross Parkinson
Director
Oct 3, 2016Award+12,254$1.02$12.50K12,254
William McKee
Director
Oct 3, 2016Award+1,470$1.02$1.50K1,470
William H. Rastetter
Director
Oct 3, 2016Award+18,382$1.02$18.75K78,689
David R. Walt
Director
Oct 3, 2016Award+11,274$1.02$11.50K178,765
Stuart A. Arbuckle
Director
Oct 3, 2016Award+5,637$1.02$5.75K5,637
Paul A. Friedman
Director
Oct 3, 2016Award+3,676$1.02$3.75K3,676
Christopherd T. Guiffre
Chief Executive Officer, Director
Jun 30, 2016Award+3,999$1.80$7.20K6,756
David R. Walt
Director
Feb 22, 2016Buy+591$2.09$1.24K167,491
David R. Walt
Director
Feb 19, 2016Buy+1,700$2.08$3.54K166,900
David R. Walt
Director
Feb 18, 2016Buy+4,500$2.09$9.41K165,200
David R. Walt
Director
Feb 17, 2016Buy+4,460$2.12$9.46K160,700
David R. Walt
Director
Feb 16, 2016Buy+4,500$2.00$9.00K156,240
David R. Walt
Director
Feb 12, 2016Buy+4,311$2.00$8.62K151,740
David R. Walt
Director
Feb 11, 2016Buy+4,350$2.03$8.83K147,429
David R. Walt
Director
Feb 10, 2016Buy+4,500$2.08$9.36K143,079
David R. Walt
Director
Feb 9, 2016Buy+4,500$2.08$9.36K138,579
David R. Walt
Director
Feb 8, 2016Buy+4,500$2.22$9.99K134,079
David R. Walt
Director
Feb 5, 2016Buy+4,500$2.29$10.31K129,579
David R. Walt
Director
Feb 4, 2016Buy+4,063$2.31$9.39K125,079
David R. Walt
Director
Feb 3, 2016Buy+4,018$2.27$9.12K121,016
David R. Walt
Director
Feb 2, 2016Buy+4,395$2.37$10.42K116,998
David R. Walt
Director
Feb 1, 2016Buy+4,500$2.37$10.67K112,603
David R. Walt
Director
Jan 29, 2016Buy+1,200$2.41$2.89K108,103
David R. Walt
Director
Jan 28, 2016Buy+4,500$2.45$11.03K106,903
David R. Walt
Director
Jan 27, 2016Buy+4,500$2.47$11.12K102,403
David R. Walt
Director
Jan 26, 2016Buy+4,300$2.44$10.49K97,903
David R. Walt
Director
Jan 25, 2016Buy+4,500$2.35$10.58K93,603
David R. Walt
Director
Jan 22, 2016Buy+4,500$2.24$10.08K89,103
David R. Walt
Director
Jan 21, 2016Buy+4,500$2.32$10.44K84,603
David R. Walt
Director
Jan 20, 2016Buy+4,500$2.35$10.58K80,103
David R. Walt
Director
Jan 19, 2016Buy+4,400$2.52$11.09K75,603
David R. Walt
Director
Jan 15, 2016Buy+4,172$2.42$10.10K71,203
David R. Walt
Director
Jan 14, 2016Buy+4,400$2.64$11.62K67,031
David R. Walt
Director
Jan 13, 2016Buy+4,384$2.69$11.79K62,631
David R. Walt
Director
Jan 12, 2016Buy+4,300$2.89$12.43K58,247
David R. Walt
Director
Jan 11, 2016Buy+4,355$2.86$12.46K53,947
David R. Walt
Director
Jan 8, 2016Buy+4,500$2.87$12.92K49,592
David R. Walt
Director
Jan 7, 2016Buy+4,300$2.87$12.34K45,092
David R. Walt
Director
Jan 6, 2016Buy+4,500$3.03$13.64K40,792
David R. Walt
Director
Jan 5, 2016Buy+4,301$3.06$13.16K36,292

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
7.12%
1M shares short
Days to cover
6.1
At 0M shares a day
Change since last report
-13.8%
From 1M shares
Short volume, 20 days
50.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Dare Bioscience's stock actually held short. Settlement fails (shares not delivered on time) peaked at 99,984 shares on Aug 19, 2026 over the last 90 days.

See a number that looks wrong?